Sponsor:
ECOG-ACRIN Cancer Research Group
Code:
NCT06475989
Conditions
Refractory Differentiated Thyroid Gland Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Cabozantinib
Computed Tomography
Dabrafenib
Magnetic Resonance Imaging
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by ECOG-ACRIN Cancer Research Group on 2024-11-18.